| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 4 |
| 1 | BARICITINIB | 4 |
| 2 | DEXAMETHASONE | 4 |
| 3 | DEXAMETHASONE 1.5 MG | 4 |
| 4 | ENOXAPARIN SODIUM | 4 |
| 5 | REMDESIVIR | 4 |
| 6 | TADALAFIL | 4 |
| 7 | 0XYGEN | 2 |
| 8 | AMIFAMPRIDINE PHOSPHATE | 2 |
| 9 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 4 | 0.0013 |
| 1 | ILOPROST | 1 | 0.0011 |
| 2 | AMIFAMPRIDINE PHOSPHATE | 2 | 0.0007 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 2 | 0.0006 |
| 4 | REMDESIVIR | 4 | 0.0003 |
| 5 | PYRIDOSTIGMINE BROMIDE | 2 | 0.0003 |
| 6 | EPOPROSTENOL | 1 | 0.0001 |
| 7 | HEPARIN SODIUM | 1 | 0.0001 |
| 8 | ENOXAPARIN SODIUM | 4 | 0.0001 |
| 9 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 4 | 0.0000 |
| 4 | Janus Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 5 | Endothelin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 6 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 7 | Prostacycline Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Calcium [EPC] | 1 | 0.0000 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 2 | 0.0000 |